<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Epidermal growth factor receptor":1,
"TTF-1":1,
"lung carcinomas":1,
"p-63":1,
"Advanced kidney cancer":1,
"Outcomes research":1,
"Targeted therapy":1,
"Thyroid&nbsp":1,
"dysfunction":1,
"Treatment-related hypothyroidism":1,
"Bone density":1,
"Osteoporosis":1,
"Thyroid cancer":18,
"Cartilage invasion patterns":1,
"Cricoid":1,
"Larynx cancer":1,
"Thyroid":11,
"lymph node metastasis":1,
"neck dissection":2,
"papillary thyroid carcinoma":12,
"risk factors":2,
"Cone-beam computed tomography":1,
"Laryngotracheal invasion":1,
"Papillary thyroid cancer":9,
"Prognosis":8,
"Surgical management":1,
"Gastric cancer":2,
"Hepatectomy":1,
"Liver metastasis":1,
"Radiofrequency ablation":1,
"Anaplastic thyroid cancer":2,
"CLM24":1,
"CLM29":1,
"Tyrosine kinases inhibitors":1,
"V600E BRAF mutation":1,
"Cancer stem cells":2,
"Drug resistance":1,
"Epithelial-mesenchymal transition":2,
"Metastatic thyroid cancer":1,
"minimally invasive surgery":1,
"minimally invasive video assisted thyroidectomy (MIVAT)":1,
"CCAR1":1,
"Hepatocellular carcinoma":2,
"BRAF":3,
"diffuse sclerosing variant":1,
"ret-PTC fusion oncoproteins":1,
"apoptosis":2,
"inhibitor of growth 4":1,
"mobility":1,
"ACTH = adrenocorticotropic hormone":1,
"BMI = body mass index":1,
"DI = diabetes insipidus":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"KPS = Karnofsky Performance Scale":1,
"LH = luteinizing hormone":1,
"TSH = thyroid-stimulating hormone":1,
"craniopharyngiomas":1,
"growth pattern":1,
"oncology":1,
"outcome":2,
"recurrence":3,
"Delphian node metastasis":1,
"Thyroglossal duct cyst cancer":1,
"midline neck mass":1,
"pyramidal lobe PTC":1,
"Adhesivo de fibrina":1,
"Fibrin tissue adhesive":1,
"Lymph node excision":1,
"Thyroidectomy":3,
"Tiroidectomía":1,
"Vaciamiento ganglionar":1,
"Conventional smear":1,
"Fine-needle aspiration":3,
"Liquid-based preparation":1,
"Telomerase":1,
"Thyroid neoplasms":6,
"Early detection of cancer":1,
"Intention":1,
"Medical overuse":1,
"HBME-1":1,
"Immunohistochemistry":3,
"ROC curve":1,
"Sensitivity":1,
"Specificity":1,
"Bilaterality":1,
"Multifocality":1,
"Cancer":8,
"LINC00663":1,
"Non-coding RNA":1,
"lncRNA":1,
"miRNA":3,
"Medullary thyroid carcinoma":6,
"Disease-free survival":2,
"Lymphocyte to monocyte ratio":1,
"Overall survival":1,
"Triple-negative breast cancer":3,
"Differentiated thyroid cancer":1,
"Radioactive iodine therapy":2,
"Thyroglobulin":3,
"Thyrotropin":1,
"Adolescents":1,
"Children":1,
"Gene expression":2,
"Radiation":1,
"Transcriptome":1,
"Familial medullary thyroid carcinoma":1,
"RET gene mutation":1,
"BRAFV600E":1,
"MUTATION":3,
"PAPILLARY THYROID MICROCARCINOMA":1,
"TERT":1,
"Asian culture":1,
"Head and neck cancer":2,
"cross-cultural differences":1,
"emotional distress":1,
"stigma":1,
"well-being":1,
"cytology":3,
"fine-needle aspiration (FNA)":2,
"preoperative diagnosis":1,
"cancers":1,
"dissection":1,
"low-risk":1,
"prophylactic":1,
"cytopathology":1,
"fine-needle biopsy":1,
"molecular pathology":1,
"thyroid nodule":3,
"Atención integral de salud":1,
"Carcinoma in situ":1,
"Comprehensive health care":1,
"Disease management":1,
"Manejo de la enfermedad":1,
"Neoplasias de la tiroides":1,
"Neoplasms":1,
"Laser":1,
"Neoplasm metastasis":1,
"Percutaneous ablation":1,
"Positron emission tomography":1,
"Thyroid neoplasm":2,
"124I":1,
"dosimetry":1,
"lesion-response relationship":1,
"radioiodine therapy":1,
"thyroid carcinoma":4,
"central neck":1,
"lymph nodes":2,
"Autoimmune disease":1,
"Autoimmune gastritis":1,
"Carcinoid":1,
"Graves’ disease":1,
"Thyroid disease":1,
"adverse events":1,
"benefit assessment":1,
"censoring":1,
"contingency tables":1,
"time-to-event data":1,
"CD133":1,
"Cancer stem cell":2,
"Invasion":2,
"Migration":2,
"Pancreatic cancer":2,
"miR-30 family":1,
"Bethesda system":1,
"pediatric":2,
"Afirma":1,
"Gene expression classifier":1,
"Precision medicine":1,
"Thyroid surgery":1,
"Follicular adenoma":1,
"Follicular carcinoma":1,
"NRAS(Q61R)":1,
"Cetuximab":1,
"Colorectal cancer":2,
"NDAT":1,
"Tetrac":1,
"Thyroid hormone":1,
"liver resection":1,
"sorafenib":2,
"Core-needle biopsy":1,
"Malignancy":2,
"AGK-BRAF":1,
"BRAF V600E":1,
"pediatric thyroid cancer":1,
"sporadic thyroid carcinoma":1,
"BRCAness":1,
"Basal-like":1,
"Breast cancer":5,
"Triple negative":1,
"Efficacy":2,
"Everolimus":2,
"Extrapancreatic neuroendocrine tumors":1,
"Neuroendocrine tumors":2,
"Safety":3,
"Chemoprevention":1,
"Colon":1,
"Familial adenomatous polyposis":1,
"Genetic":1,
"infarction":1,
"management":3,
"vanishing cancer":1,
"cellular diagnostics":1,
"image analysis":1,
"machine learning":1,
"LC3":1,
"autophagy":2,
"puncta":1,
"Endoscopic transsphenoidal surgery":1,
"Macroadenoma":1,
"Pituitary function":1,
"Pituitary surgery":1,
"Endometrium":1,
"Large cell neuroendocrine carcinoma":1,
"Metastatic carcinoma":1,
"Brain tumor":1,
"Late-effect":1,
"Medication":1,
"Survivor":2,
"Gray level co-occurrence matrix":1,
"Pre-compression":1,
"Shear wave elastography":1,
"Spatial heterogeneity":1,
"Texture analysis":1,
"Myo-D":1,
"neuromuscular electrical stimulation therapy (NMES)":1,
"radiation therapy (RT)":1,
"traditional swallow therapy (TST)":1,
"transforming growth factor beta (TGF-β)":1,
"Biopsy":1,
"Pain":1,
"Parallel":1,
"Perpendicular":1,
"Thyroid gland":3,
"Apolipoprotein L1":1,
"Cohort-study":1,
"Comorbidity":1,
"Parkinson's disease":1,
"FNAB":1,
"thyroid paraganglioma":1,
"febrile neutropenia":1,
"prospective cohort":1,
"Exposure–toxicity":1,
"Individualized dosing":1,
"Pharmacogenetics":1,
"Population pharmacokinetics":1,
"Mitochondrial disorder":1,
"Neoplasm":2,
"Oncogenesis":1,
"Oxidative stress":2,
"Tumour":1,
"mtDNA":1,
"Hypothyroidism":1,
"child":1,
"FOXE1":1,
"genome-wide association studies":1,
"meta-analysis":4,
"rs965513":1,
"CREB":1,
"GRK3":1,
"androgen deprivation therapy":1,
"neuroendocrine prostate cancer":1,
"Computer-aided diagnosis":1,
"Medical imaging":1,
"Morphometry":1,
"Cytokine":1,
"Immunotherapy":1,
"Interleukin-24":1,
"T cells":1,
"Tumor microenvironment":1,
"Sprague-Dawley rats":1,
"carcinogenic synergism between S-50 Hz MF plus formaldehyde":1,
"hemolymphoreticular neoplasias":1,
"life-span bioassays":1,
"thyroid C-cell carcinomas":1,
"ATG4B":1,
"MAP1LC3A R70H":1,
"luciferase release assay":1,
"Embryonic develop-associated gene 1 (EDAG-1)":1,
"PI3K/Akt pathway":1,
"Proliferation":2,
"Basal cell carcinoma":1,
"Second primary cancer":1,
"Skin":1,
"Sun exposure":1,
"SAHA":1,
"genetically engineered mouse model":1,
"thyroid hormone receptors":1,
"tumor suppressor PTEN":1,
"tumorigenesis":1,
"vorinostat":1,
"folic acid":1,
"high vitamin intake":1,
"research recommendations":1,
"Incidence":2,
"Parathyroid Glands":1,
"Parathyroidectomy":1,
"DNA methylation":1,
"PDAC":1,
"mucin":1,
"pancreas":2,
"Atypia of undetermined significance":1,
"Morphometric analysis":1,
"BRCA":1,
"Familial cancers":1,
"Genetic counseling":1,
"Ovarian cancer":2,
"lymphovascular invasion":1,
"survival":1,
"VASP":1,
"basal-like subtype breast cancer":1,
"berberine":1,
"polymerization":1,
"lenvatinib":1,
"NanoString analysis":1,
"diagnostic biomarkers":1,
"follicular thyroid carcinoma":1,
"poorly differentiated thyroid carcinoma":1,
"Hashimoto's thyroiditis":1,
"adolescent":1,
"papillary carcinoma of the thyroid":1,
"Liver X receptor":1,
"inflammation":1,
"lipid metabolism":1,
"macrophage":1,
"peripheral squamous cell lung carcinoma":1,
"AKT":2,
"IGF-1":1,
"PKM2":1,
"STAT5":1,
"phosphorylation of PKM2":1,
"NIR imaging":1,
"nanoparticle":1,
"siRNA delivery":1,
"theranostic":1,
"differentiated thyroid carcinoma":2,
"microRNA":1,
"quantitative RT-PCR method":1,
"receiver operating characteristic curve":1,
"long noncoding RNA":1,
"mRNA":1,
"microarray":1,
"metastasis":1,
"misdiagnosis":1,
"nasopharyngeal carcinoma":2,
"O-linked N-acetylglucosamine glycosylation":1,
"O-linked N-acetylglucosamine transferase":1,
"chemoresistance":1,
"differentiation":1,
"tumor spheres":1,
"serum thyrotropin":1,
"Small cell lung cancer":1,
"TTF1 expression":1,
"irradiation":1,
"outcomes":1,
"predictive factors":1,
"adjuvant chemotherapy":1,
"concurrent chemoradiotherapy":1,
"neoadjuvant chemotherapy":1,
"ART3":1,
"ERK":1,
"Adrenal gland":1,
"Gastrointestinal tract":1,
"Lungs":1,
"Ca thyroid":1,
"I-131 capsules":1,
"I-131 radiation safety":1,
"capsule administration":1,
"Dual malignancy":1,
"false positive":1,
"prostate cancer":1,
"prostate-specific membrane antigen positron emission tomography-computed tomography":1,
"urothelial carcinoma ureter":1,
"Papillary carcinoma":1,
"radioiodine":1,
"renal metastasis":1,
"DTC":1,
"Oncogene":1,
"PTC":1,
"Saudi Arabia":1,
"Cordless phone":1,
"Ionizing radiation":1,
"Mobile phone":1,
"NORDCAN":1,
"Nordic countries":1,
"RF-EMF":1,
"Radiofrequency electromagnetic fields":1,
"Swedish Cancer Register":1,
"Hypertrophic cardiomyopathy":1,
"Radiofrequency catheter ablation":1,
"Robotic surgical procedure":1,
"Treatment outcome":1,
"Adjuvant":1,
"Adjuvante":1,
"Cancer médullaire de la thyroïde":1,
"Contrôle local":1,
"External beam radiotherapy":1,
"IMRT":1,
"Local control":1,
"Modulation d’intensité":1,
"Postoperative":1,
"Postopératoire":1,
"Radiothérapie externe":1,
"Jaw tumors":1,
"Metastatic follicular carcinoma thyroid":1,
"E-cadherin":1,
"epidermal growth factor receptor (EGFR)":1,
"tenascin C":1,
"thyroid transcription factor-1 (TTF-1)":1,
"adenocarcinoma":1,
"napsin A":1,
"non-small cell lung cancer":1,
"p40 (ΔNp63)":1,
"small biopsy":1,
"squamous cell carcinoma":1,
"Body habitus":1,
"Robotic thyroidectomy":1,
"EMMPRIN":1,
"MMP-9":1,
"RNA interference (RNAi)":1,
"lentivirus":1,
"short hairpin RNA (shRNA)":1,
"quality of life":1,
"total thyroidectomy":1,
"transaxillary approach":1,
"cardiovascular and respiratory diseases":1,
"environment and health":1,
"metabolic diseases":1,
"occupational exposures and diseases":1,
"pollution":1,
"thyroid dysfunctions":1,
"Complications":1,
"Cricoid cartilage":1,
"Laryngeal infiltration":1,
"Hyperthyroidism":1,
"Case report":1,
"Distant metastasis":1,
"Epigastric pain":1,
"Gastric mucosa":1,
"Tyrosine kinase inhibitors":1,
"actin":1,
"adaptor protein":1,
"endocytosis":1,
"phosphatidylinositol 3-kinase":1,
"protein self-assembly":1,
"Human telomerase reverse transcriptase (hTERT)":1,
"gene polymorphism":1,
"life quality evaluation":1,
"rs10069690C/T":1,
"rs2736100G/T":1,
"Biochemical Tumor Markers":1,
"Iodine":1,
"Endoderm":1,
"Mixed medullary-follicular carcinoma":1,
"Neural crest":1,
"Neuroendocrine tumours":1,
"Thyroid C cells":1,
"Ultimobranchial body":1,
"Endocrine tumors":1,
"Genetics":1,
"Mutations":2,
"Succinate dehydrogenase":1,
"Body mass index":1,
"Fine-needle aspiration cytology":1,
"Morbid obesity":1,
"Glioblastoma":1,
"Hematological malignancies":1,
"Lung cancer":1,
"Melanoma":1,
"Solid tumors":1,
"Carcinoma":1,
"FNAC":1,
"Immunocytochemistry":1,
"diagnosis":1,
"pathology":1,
"ultrasonography":1,
"Hurthle cell neoplasm":1,
"Hurthle cell thyroid carcinoma":1,
"antioxidant genes":1,
"papillary thyroid cancer (PTC)":1,
"radioiodine (J131)":1,
"Cystic papillary carcinoma":1,
"fine-needle aspiration cytology (FNAC)":1,
"hemophagocytosis":1,
"Association":1,
"Mitochondrial DNA (mtDNA)":1,
"Mitochondrial transfer RNA (mt-tRNA)":1,
"Variants":1,
"therapy":1,
"Brain metastasis":1,
"Disease-free interval":1,
"Multi-modal therapy":1,
"Prognosticanalysis":1,
"Genetic testing":1,
"RET proto-oncogene":1,
"retrospective study":1,
"Nthy-ori-3-1 cells":1,
"amitrole":1,
"cancer-related genes":1,
"expression profile":1,
"Percutaneous Ethanol Injection Therapy":1,
"parathyroid adenoma":1,
"follow-up":1,
"radioiodine ablation":1,
"well differentiated thyroid carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年7月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
